表紙
市場調查報告書

病患監測設備的全球市場 - 機會分析、產業預測 (2020-2027年):各產品類型、終端用戶

Patient Monitoring Devices Market by Product Type and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 955599
出版日期 內容資訊 英文 319 Pages
商品交期: 2-3個工作天內
價格
病患監測設備的全球市場 - 機會分析、產業預測 (2020-2027年):各產品類型、終端用戶 Patient Monitoring Devices Market by Product Type and End User : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年07月01日內容資訊: 英文 319 Pages
簡介

全球病患監測設備的市場規模,2019年達257億6856萬美金,預計至2027年達448億6156萬美元,從2020年到2027年,預計以4.4%的年複合成長率擴大。市場在預測期間內預計大幅度成長。成長的要素,是老年人口的增加及遠端患者監護設備的採用增加等。再加上企業,醫院,及學術機構間的合作,增加市場收益,預期推動市場成長。

本報告提供全球病患監測設備市場相關調查,市場概要與動態,各市場區隔、各地區的市場規模的分析與預測,並提供主要企業簡介等資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
    • 主要的投資口袋
    • 最高的勝利策略
  • 主要企業的地位
  • 波特的五力分析
  • COVID-19對市場的影響
  • 政府的法規
    • 美國FDA
    • CE標誌
    • 衛生署(MHLW)
  • 醫療費償付方案
  • 臨床試驗
  • 專利分析
    • 登記/核准專利
    • 登記/核准專利:各申請人
    • 美國的專利分析:各申請人
    • PCT的專利分析:各申請人
    • 歐洲的專利分析:各申請人
    • 中國的專利分析:各申請人
    • 澳洲的專利分析:各申請人
  • 市場動態
    • 促進因素
      • 文明病的擴大
      • 老年人口的增加
      • 遠端患者監護設備的採用增加
    • 阻礙因素
      • 政府的法規和醫療費償付的問題
      • 認識不足和高成本
    • 市場機會
      • 新興各國的未開發市場
      • 技術的進步

第4章 病患監測設備市場:各產品類型

  • 概要
    • 市場規模、預測
  • 血液循環動態監測設備
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
    • 血糖值監測器
      • 市場規模、預測
    • 血氣及電解質分析設備/監測器
    • 血壓計
  • 神經監測設備
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
    • 腦波計(EEG)
      • 市場規模、預測
    • 經顱都卜勒超音波(TCD)
    • 腦磁計(MEG)
    • 顱內壓監測器(ICP)
    • 腦血氧計
  • 心臟監測設備
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
    • 心電圖(ECG)設備
      • 各類型
      • 領導各類型
      • 市場規模、預測
    • 心電圖監測
      • 市場規模、預測
    • 心臟事件記錄器
      • 各類型
      • 各技術
      • 市場規模、預測
    • 其他(嵌入式循環記錄儀,心摶出量監測器等)
      • 市場規模、預測
  • 胎兒新生兒監測設備
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
    • 超音波
      • 市場規模、預測
    • 電子胎兒監測設備
    • 多普勒胎兒心率儀監視設備
    • 其他
  • 呼吸監測器
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
    • 二氧化碳測量儀
      • 市場規模、預測
    • 脈搏血氧飽和度分析儀
    • 睡眠呼吸中止症監測器
    • 肺活量計
  • 多參數監視設備
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
    • 重病
      • 市場規模、預測
    • 中症
    • 輕症
  • 遠端患者監護設備
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
  • 體重監測設備
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
  • 體溫監測設備
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國
  • 尿量監測
    • 主要的市場趨勢、機會
    • 市場規模、預測
    • 市場佔有率分析:各國

第5章 病患監測設備市場:各終端用戶

  • 概要
    • 市場規模、預測
  • 醫院
    • 市場規模、預測
    • 市場佔有率分析:各國
  • 居家醫療
  • 門診病人手術中心(ASC)

第6章 病患監測設備市場:各地區

  • 概要
    • 市場規模、預測
  • 北美
    • 主要的機會、預測
    • 市場規模、預測
      • 美國的市場規模、預測
      • 加拿大的市場規模、預測
      • 墨西哥的市場規模、預測
  • 歐洲
    • 主要的機會、預測
    • 市場規模、預測
      • 德國的市場規模、預測
      • 法國的市場規模、預測
      • 英國的市場規模、預測
      • 義大利的市場規模、預測
      • 西班牙的市場規模、預測
      • 其他歐洲的市場規模、預測
  • 亞太地區
    • 主要的機會、預測
    • 市場規模、預測
      • 日本的市場規模、預測
      • 中國的市場規模、預測
      • 澳洲的市場規模、預測
      • 印度的市場規模、預測
      • 韓國的市場規模、預測
      • 其他亞太地區的市場規模、預測
  • 南美、中東、非洲
    • 主要的機會、預測
    • 市場規模、預測
      • 巴西的市場規模、預測
      • 土耳其的市場規模、預測
      • 委內瑞拉的市場規模、預測
      • 沙烏地阿拉伯的市場規模、預測
      • 其他LAMEA的市場規模、預測

第7章 企業簡介

  • ABBOTT LABORATORIES
  • BIOTRONIK SE & CO. KG
  • GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
  • F. HOFFMANN-LA ROCHE LTD.
  • JOHNSON & JOHNSON
  • KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
  • MASIMO CORPORATION
  • MEDTRONIC PLC.
  • 日本光電
  • OMRON
目錄
Product Code: A01338

Title:
Patient Monitoring Devices Market by Product Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices) and End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global patient monitoring devices market was $25,768.56 million in 2019, and is projected to reach $44,861.56 million by 2027 at a CAGR of 4.4% from 2020 to 2027.

Patient monitoring devices are used to observe vital signs such as respiration and heart rate of patients. With advancements in wireless technology, these devices can be used remotely to monitor physiological parameters of patients. Patient monitoring devices such as pulse oximeters, capnographs, and cardiac monitors are increasingly being used in hospitals, clinics, and various outpatient centers. These devices are commonly used during minor and major surgeries to monitor physiological signs of patients and intervene, if any complication occurs. These devices can also help healthcare professionals to monitor vital signs of multiple patients at the same time. Some of these devices are also used to alert physicians, in case the parameter levels are either above or below the limit set by physicians. Moreover, with the help of remote monitoring devices, physicians can remotely monitor physiological parameters such as blood glucose level, blood pressure, and heart rate; and accordingly provide appropriate treatment for patients.

The market is expected to witness a significant growth during the forecast period. The growth can be attributed to increase in geriatric population and rise in adoption of remote patient monitoring devices. Rise in prevalence of patients suffering from different lifestyle diseases such as diabetes, cancer, and atherosclerosis also contribute toward the growth of the patient monitoring devices market. Moreover, collaborations between companies, hospitals, and academic institutions are expected to increase the market revenue and, therefore, boost the market growth. However, cost associated with these products and lack of awareness among patients hinders the market growth. Moreover, government regulations and reimbursement issues also restrain growth of the patient monitoring devices market.

The global patient monitoring devices market is segmented on the basis of product type, end user, and region. By product type, it is divided into hemodynamic monitoring, neuromonitoring, cardiac monitoring, fetal & neonatal monitoring, respiratory monitoring, multi-parameter monitoring, remote patient monitoring, weigh monitoring, and temperature monitoring devices. On the basis of end user it is segmented into hospitals, home settings, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

The report provides an extensive analysis of the current market trends and future estimations in the patient monitoring devices market.

The market scenario is comprehensively analyzed with respect to the device types and end users.

The market estimations are based on high-end analysis of the key developments from 2019-2027.

Recent developments and key manufacturers are listed to understand the competitive market scenario.

In-depth geographical analysis provides an understanding of the regional market, which assists in strategic business planning.

Key Market Segments

By Product

  • Hemodynamic Monitoring Devices
  • Blood Glucose
  • Cholesterol
  • Blood Gas & Electrolyte Analyzers/Monitors
  • Blood Pressure
  • Neuromonitoring Devices
  • Electroencephalograph (EEG) Devices
  • Transcranial Dopplers (TCD)
  • Magnetoencephalography (MEG) Devices
  • Intracranial Pressure Monitors (ICP)
  • Cerebral Oximeters
  • Cardiac Monitoring Devices
  • Electrocardiogram (ECG) Devices
  • Holter Monitor
  • Event Monitors
  • Others
  • Fetal & Neonatal Monitoring Devices
  • Ultrasound
  • Electronic Fetal Monitoring Devices
  • Fetal Doppler Monitoring Devices
  • Other Fetal & Neonatal Monitoring Devices
  • Respiratory Monitoring Devices
  • Capnographs
  • Spirometers
  • Sleep Apnea Monitor
  • Pulse Oximeters
  • Multiparameter Monitoring Devices
  • High Acuity
  • Mid Acuity
  • Low Acuity
  • Remote Patient Monitoring Devices
  • Weight Monitoring Devices
  • Temperature Monitoring Devices

By End User

  • Hospitals & Clinics
  • Home Settings
  • Ambulatory Surgical Centers (ASCs)

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Turkey
  • Venezuela
  • Saudi Arabia
  • Rest of LAMEA
  • List of key players profiled in the report
  • Medtronic, Inc.
  • Biotronik
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Ltd
  • Masimo Corporation
  • Nihon Kohden Corporation
  • Johnson and Johnson
  • Omron Healthcare Co. Ltd.
  • Abbott Laboratories
  • Koninklijke Philips N.V.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits
  • 1.3.Key market segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Top Player Positioning
  • 3.4.Porter's five forces analysis
  • 3.5.COVID-19 impact on the market
  • 3.6.Government regulations
    • 3.6.1.U.S. FDA
    • 3.6.2.European Conformity (CE) mark
    • 3.6.3.Ministry of Health, Labor, and Welfare (MHLW)
  • 3.7.Reimbursement scenarios
  • 3.8.Clinical trials
  • 3.9.Patent analysis
    • 3.9.1.Patents Registered/Approved, 2011-2020
    • 3.9.2.Patents Registered/Approved, by Applicants, 2011-2020
    • 3.9.3.U.S. patent analysis, by market applicants
    • 3.9.4.PCT patent analysis, by market applicants
    • 3.9.5.Europe patent analysis, by market applicants
    • 3.9.6.China patent analysis, by market applicants
    • 3.9.7.Australia patent analysis by market applicants
  • 3.10.Market Dynamics
    • 3.10.1.Drivers
      • 3.10.1.1.Rise in prevalence of lifestyle diseases
      • 3.10.1.2.Increase in geriatric population
      • 3.10.1.3.Rise in the adoption of remote patient monitoring devices
    • 3.10.2.Restraints
      • 3.10.2.1.Government regulations and reimbursement issues
      • 3.10.2.2.Limited awareness and high costs
    • 3.10.3.Opportunities
      • 3.10.3.1.Untapped markets in developing countries
      • 3.10.3.2.Technological advancements

CHAPTER 4:PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Hemodynamic monitoring devices
    • 4.2.1.Key market trends and opportunity
    • 4.2.2.Market size and forecast
    • 4.2.3.Market share analysis, by country
    • 4.2.4.Blood glucose monitors
      • 4.2.4.1.Market size and forecast
    • 4.2.5.Blood gas and electrolyte analyzers/monitors
      • 4.2.5.1.Market size and forecast
    • 4.2.6.Blood pressure monitors
      • 4.2.6.1.Market size and forecast
  • 4.3.Neuromonitoring devices
    • 4.3.1.Key market trends and opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market share analysis, by country
    • 4.3.4.Electroencephalograph (EEG) devices
      • 4.3.4.1.Market size and forecast
    • 4.3.5.Transcranial dopplers (TCD)
      • 4.3.5.1.Market size and forecast
    • 4.3.6.Magnetoencephalograph (MEG) devices
      • 4.3.6.1.Market size and forecast
    • 4.3.7.Intracranial pressure monitors (ICP)
      • 4.3.7.1.Market size and forecast
    • 4.3.8.Cerebral oximeters
      • 4.3.8.1.Market size and forecast
  • 4.4.Cardiac monitoring devices
    • 4.4.1.Key market trends and opportunities
    • 4.4.2.Market size and forecast
    • 4.4.3.Market share analysis, by country
    • 4.4.4.Electrocardiogram (ECG) devices
      • 4.4.4.1.By type
      • 4.4.4.2.By lead type
      • 4.4.4.3.Market size and forecast
    • 4.4.5.Holter monitors
      • 4.4.5.1.Market size and forecast
    • 4.4.6.Event monitors
      • 4.4.6.1.By type
      • 4.4.6.2.By technology
      • 4.4.6.3.Market size and forecast
    • 4.4.7.Others (Implantable loop recorder, Cardiac output monitor and others)
      • 4.4.7.1.Market size and forecast
  • 4.5.Fetal neonatal monitoring devices
    • 4.5.1.Key market trends and opportunities
    • 4.5.2.Market size and forecast
    • 4.5.3.Market share analysis, by country
    • 4.5.4.Ultrasound
      • 4.5.4.1.Market size and forecast
    • 4.5.5.Electronic Fetal Monitoring Devices
      • 4.5.5.1.Market size and forecast
    • 4.5.6.Fetal Doppler Monitoring Devices
      • 4.5.6.1.Market size and forecast
    • 4.5.7.Others
      • 4.5.7.1.Market size and forecast
  • 4.6.Respiratory monitors
    • 4.6.1.Key market trends and opportunities
    • 4.6.2.Market size and forecast
    • 4.6.3.Market share analysis, by country
    • 4.6.4.Capnographs
      • 4.6.4.1.Market size and forecast
    • 4.6.5.Pulse oximeters
      • 4.6.5.1.Market size and forecast
    • 4.6.6.Sleep apnea monitors
      • 4.6.6.1.Market size and forecast
    • 4.6.7.Spirometers
      • 4.6.7.1.Market size and forecast
  • 4.7.Multiparameter monitoring devices
    • 4.7.1.Key market trends and opportunities
    • 4.7.2.Market size and forecast
    • 4.7.3.Market share analysis, by country
    • 4.7.4.High acuity
      • 4.7.4.1.Market size and forecast
    • 4.7.5.Mid acuity
      • 4.7.5.1.Market size and forecast
    • 4.7.6.Low acuity
      • 4.7.6.1.Market size and forecast
  • 4.8.Remote patient monitoring devices
    • 4.8.1.Key market trends and opportunities
    • 4.8.2.Market size and forecast
    • 4.8.3.Market share analysis, by country
  • 4.9.Weight monitoring devices
    • 4.9.1.Key market trends and opportunities
    • 4.9.2.Market size and forecast
    • 4.9.3.Market share analysis, by country
  • 4.10.Temperature monitoring devices
    • 4.10.1.Key market trends and opportunities
    • 4.10.2.Market size and forecast
    • 4.10.3.Market share analysis, by country
  • 4.11.Urine output monitoring
    • 4.11.1.Key market trends and opportunities
    • 4.11.2.Market size and forecast
    • 4.11.3.Market share analysis, by country

CHAPTER 5:PATIENT MONITORING DEVICES MARKET, BY END USER

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Hospitals
    • 5.2.1.Market size and forecast
    • 5.2.2.Market share analysis, by country
  • 5.3.Home settings
    • 5.3.1.Market size and forecast
    • 5.3.2.Market share analysis, by country
  • 5.4.Ambulatory surgical centers (ASCs)
    • 5.4.1.Market size and forecast
    • 5.4.2.Market share analysis, by country

CHAPTER 6:PATIENT MONITORING DEVICES MARKET, BY REGION

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.North America
    • 6.2.1.Key opportunities and forecast
    • 6.2.2.Market size and forecast
      • 6.2.2.1.U.S. market size and forecast
      • 6.2.2.2.Canada market size and forecast
      • 6.2.2.3.Mexico market size and forecast
  • 6.3.Europe
    • 6.3.1.Key opportunities and forecast
    • 6.3.2.Market size and forecast
      • 6.3.2.1.Germany market size and forecast
      • 6.3.2.2.France market size and forecast
      • 6.3.2.3.UK market size and forecast
      • 6.3.2.4.Italy market size and forecast
      • 6.3.2.5.Spain market size and forecast
      • 6.3.2.6.Rest of Europe market size and forecast
  • 6.4.Asia-Pacific
    • 6.4.1.Key opportunities and forecast
    • 6.4.2.Market size and forecast
      • 6.4.2.1.Japan market size and forecast
      • 6.4.2.2.China market size and forecast
      • 6.4.2.3.Australia market size and forecast
      • 6.4.2.4.India market size and forecast
      • 6.4.2.5.South Korea market size and forecast
      • 6.4.2.6.Rest of Asia-Pacific market size and forecast
  • 6.5.LAMEA
    • 6.5.1.Key opportunities and forecast
    • 6.5.2.Market size and forecast
      • 6.5.2.1.Brazil market size and forecast
      • 6.5.2.2.Turkey market size and forecast
      • 6.5.2.3.Venezuela market size and forecast
      • 6.5.2.4.Saudi Arabia market size and forecast
      • 6.5.2.5.Rest of LAMEA market size and forecast

CHAPTER 7:COMPANY PROFILES

  • 7.1.ABBOTT LABORATORIES
    • 7.1.1.Company overview
    • 7.1.2.Company snapshot
    • 7.1.3.Operating business segments
    • 7.1.4.Product portfolio
    • 7.1.5.Business performance
    • 7.1.6.Key strategic moves and developments
  • 7.2.BIOTRONIK SE & CO. KG
    • 7.2.1.Company overview
    • 7.2.2.Company snapshot
    • 7.2.3.Operating business segments
    • 7.2.4.Product portfolio
    • 7.2.5.Key strategic moves and developments
  • 7.3.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)
    • 7.3.1.Company overview
    • 7.3.2.Company snapshot
    • 7.3.3.Operating business segments
    • 7.3.4.Product portfolio
    • 7.3.5.Business performance
    • 7.3.6.Key strategic moves and developments
  • 7.4.F. HOFFMANN-LA ROCHE LTD.
    • 7.4.1.Company overview
    • 7.4.2.Company snapshot
    • 7.4.3.Operating business segments
    • 7.4.4.Product portfolio
    • 7.4.5.Business performance
    • 7.4.6.Key strategic moves and developments
  • 7.5.JOHNSON & JOHNSON
    • 7.5.1.Company overview
    • 7.5.2.Company snapshot
    • 7.5.3.Operating business segments
    • 7.5.4.Product portfolio
    • 7.5.5.Business performance
    • 7.5.6.Key strategic moves and developments
  • 7.6.KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
    • 7.6.1.Company overview
    • 7.6.2.Company snapshot
    • 7.6.3.Operating business segments
    • 7.6.4.Product portfolio
    • 7.6.5.Business performance
    • 7.6.6.Key strategic moves and developments
  • 7.7.MASIMO CORPORATION
    • 7.7.1.Company overview
    • 7.7.2.Company snapshot
    • 7.7.3.Product portfolio
    • 7.7.4.Business performance
    • 7.7.5.Key Strategic Moves and Developments
  • 7.8.MEDTRONIC PLC.
    • 7.8.1.Company overview
    • 7.8.2.Company snapshot
    • 7.8.3.Operating business segments
    • 7.8.4.Medtronic offers following patient monitoring devices
    • 7.8.5.Business performance
    • 7.8.6.Key strategic moves and developments
  • 7.9.NIHON KOHDEN CORPORATION
    • 7.9.1.Company overview
    • 7.9.2.Company snapshot
    • 7.9.3.Operating business segments
    • 7.9.4.Product portfolio
    • 7.9.5.Business performance
    • 7.9.6.Key strategic moves and developments
  • 7.10.OMRON CORPORATION
    • 7.10.1.Company overview
    • 7.10.2.Company snapshot
    • 7.10.3.Operating business segments
    • 7.10.4.Product portfolio
    • 7.10.5.Business performance
    • 7.10.6.Key Strategic Moves and Development

LIST OF TABLES

  • TABLE 01.CLINICAL TRIALS: PATIENT MONITORING DEVICES MARKET, 2013-2020
  • TABLE 02.PATENTS REGISTERED/APPROVED ACROSS THE GLOBE, 2011-2020
  • TABLE 03.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011-2020
  • TABLE 04.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011- 2020
  • TABLE 05.PCT PATENT ANALYSIS, BY APPLICANTS, 2011-2020
  • TABLE 06.EUROPE PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
  • TABLE 07.CHINA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
  • TABLE 08.AUSTRALIA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
  • TABLE 09.GLOBAL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 10.HEMODYNAMIC MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 11.HEMODYNAMIC MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.BLOOD GAS & ELECTROLYTE ANALYSERS MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.BLOOD PRESSURE MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.NEUROMONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 16.NEUROMONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 17.ELECTROENCEPHALOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.TRANSCRANIAL DOPPLERS MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.MAGNETOENCEPHALOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 20.INTRACRANIAL PRESSURE MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 21.CEREBRAL OXIMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 22.CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 23.CARDIAC MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 24.ELECTROCARDIOGRAM MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 25.HOLTER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 26.EVENT MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 27.OTHER CARDIAC MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 28.FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 29.FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 30.ULTRASOUND MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 31.ELECTRONIC FETAL MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 32.FETAL DOPPLER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 33.OTHER FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 34.RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 35.RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 36.CAPNOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 37.PULSE OXIMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 38.SLEEP APNEA MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 39.SPIROMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 40.MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 41.MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 42.HIGH ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 43.MID ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 44.LOW ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 45.REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 46.WEIGHT MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 47.TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
  • TABLE 48.PATIENT MONITORING DEVICES MARKET FOR URINE MONITORING DEVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 49.GLOBAL PATIENT MONITORING DEVICES MARKET, BY END USER 2019-2027 ($MILLION)
  • TABLE 50.PATIENT MONITORING DEVICES MARKET IN HOSPITALS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 51.PATIENT MONITORING DEVICES MARKET IN HOME SETTING, BY REGION, 2019-2027 ($MILLION)
  • TABLE 52.PATIENT MONITORING DEVICES MARKET IN AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 53.PATIENT MONITORING DEVICES MARKET, BY REGION, 2019-2027($MILLION)
  • TABLE 54.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 55.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 56.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019-2027($MILLION)
  • TABLE 57.U.S. PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 58.U.S. PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 59.CANADA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 60.CANADA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 61.MEXICO PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 62.MEXICO PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 63.EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 64.EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 65.EUROPE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019-2027($MILLION)
  • TABLE 66.GERMANY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 67.GERMANY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 68.FRANCE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 69.FRANCE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 70.UK PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 71.UK PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 72.ITALY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 73.ITALY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 74.SPAIN PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 75.SPAIN PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 76.REST OF EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 77.REST OF EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 78.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 79.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 80.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019-2027($MILLION)
  • TABLE 81.JAPAN PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 82.JAPAN PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 83.CHINA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 84.CHINA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 85.AUSTRALIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 86.AUSTRALIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 87.INDIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 88.INDIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 89.SOUTH KOREA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 90.SOUTH KOREA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 91.REST OF ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 92.REST OF ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 93.LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 94.LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 95.LAMEA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019-2027($MILLION)
  • TABLE 96.BRAZIL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 97.BRAZIL PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 98.TURKEY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 99.TURKEY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 100.VENEZUELA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 101.VENEZUELA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 102.SAUDI ARABIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 103.SAUDI ARABIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 104.REST OF LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019-2027($MILLION)
  • TABLE 105.REST OF LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019-2027($MILLION)
  • TABLE 106.ABBOTT: COMPANY SNAPSHOT
  • TABLE 107.ABBOTT: OERATING SEGMENT
  • TABLE 108.ABBOTT: PRODUCT PORTFOLIO
  • TABLE 109.BIOTRONIK: COMPANY SNAPSHOT
  • TABLE 110.BIOTRONIK: OPERATING SEGMENTS
  • TABLE 111.BIOTRONIK: PRODUCT PORTFOLIO
  • TABLE 112.GE: COMPANY SNAPSHOT
  • TABLE 113.GE: OPERATING SEGMENTS
  • TABLE 114.GE: PRODUCT PORTFOLIO
  • TABLE 115.ROCHE: COMPANY SNAPSHOT
  • TABLE 116.ROCHE: OERATING SEGMENT
  • TABLE 117.ROCHE: PRODUCT PORTFOLIO
  • TABLE 118.J&J: COMPANY SNAPSHOT
  • TABLE 119.J&J: OPERATING SEGMENTS
  • TABLE 120.J&J: PRODUCT PORTFOLIO
  • TABLE 121.PHILIPS: COMPANY SNAPSHOT
  • TABLE 122.PHILIPS: OPERATING SEGMENTS
  • TABLE 123.PHILIPS: PRODUCT PORTFOLIO
  • TABLE 124.MASIMO: COMPANY SNAPSHOT
  • TABLE 125.MASIMO: PRODUCT PORTFOLIO
  • TABLE 126.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 127.MEDTRONIC: OPERATING BUSINESS SEGMENTS
  • TABLE 128.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 129.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
  • TABLE 130.GSK: PRODUCT PORTFOLIO
  • TABLE 131.OMRON CORPORATION: COMPANY SNAPSHOT
  • TABLE 132.OMRON CORPORATION: OPERATING SEGMENTS
  • TABLE 133.OMRON CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.TOP INVESTMENT POCKETS: GLOBAL PATIENT MONITORING DEVICES MARKET, BY DEVICE TYPE
  • FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2017-2020*
  • FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2020* (%)
  • FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017-2020* (%)
  • FIGURE 05.TOP PLAYER POSITIONING
  • FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 07.HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.HIGH THREAT OF NEW ENTRANTS
  • FIGURE 09.MODERATE THREAT OF SUBSTITUTION
  • FIGURE 10.HIGH COMPETITIVE RIVALRY
  • FIGURE 11.PATENTS REGISTERED/APPROVED, 2011-2020
  • FIGURE 12.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011-2020
  • FIGURE 13.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
  • FIGURE 14.PCT PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
  • FIGURE 15.EUROPE PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
  • FIGURE 16.CHINA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011-2020
  • FIGURE 17.AUSTRALIA PATENT ANALYSIS BY MARKET APPLICANTS, 2011-2020
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HEMODYNAMIC PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF NEUROMONITORING PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF CARDIAC PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF FETAL AND NEONATAL MONITORING PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF RESPIRATORY PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF MULTIPARAMETER PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF REMOTE PATEINT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF WEIGHT PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF TEMPERATURE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF URINE OUTPUT PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HOSPITAL PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 29.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HOME SETTINGS PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 30.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF AMBULATORY SURGICAL CENTERS PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
  • FIGURE 31.ABBOTT: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 32.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 33.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 34.GE: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 35.GE: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 36.GE: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 37.ROCHE: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 38.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 39.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 40.J&J: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 41.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 42.J&J: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 43.PHILIPS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 44.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 45.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
  • FIGURE 46.MASIMO: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 47.MASIMO: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 48.MEDTRONIC: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 49.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 50.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
  • FIGURE 51.NIHON KOHDEN: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 52.NIHON KOHDEN: REVENUE SHARE, BY PRODUCT SEGMENT, 2018 (%)
  • FIGURE 53.NIHON KOHDEN: REVENUE SHARE, BY REGION, 2018 (%)
  • FIGURE 54.OMRON CORPORATION: NET SALES, 2016-2018 ($MILLION)
  • FIGURE 55.OMRON CORPORATION: REVENUE SHARE, BY SEGMENT, 2018 (%)
  • FIGURE 56.OMRON CORPORATION: REVENUE SHARE, BY REGION, 2018 (%)